Doug Long, IQVIAs vice president of industry relations, caught up with Pharma Commerce at the Asembia AXS25 Summit 5 to discuss exactly that
The Findings Should Be Taken With a Grain of Salt The findings bring attention to symptoms that arent consistently reported in GLP-1 clinical trials, or symptoms that failed to meet the threshold for reporting, wrote the authors
Foundayo: A Flexible Oral Option Approved in April 2026, Foundayo is the latest FDA-approved GLP-1 weight loss medication, offering a once-daily oral option that can be taken at any time, with or without food, and without water restrictions
Side Effects Both forms of semaglutide can cause side effects, most commonly gastrointestinal issues like nausea, vomiting, and abdominal pain
However, some may experience side effects like nausea initially